Biosimilars in Spain: an exponential opportunity with adequate policies

News about our members

18th October 2021BioSim News

Biogen has contributed to an estimated saving of 2,4 million euros in Europe with its anti-TNF biosimilar therapies

READ MORE

recently published

Post thumb
BioSim subscribes to the Pharmaceutical Industry Strategy, approved by the Council of Ministers
11 2024 December
Post thumb
Medicines for Europe calls on the EU to take strategic action on generics and biosimilars
09 2024 December
Post thumb
The BioSim Ethics Commission presents its recommendations on the use of biosimilars
09 2024 December
Post thumb
VI National Conference on Biosimilars
November 21 2024

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

PRIVACY POLICY

SUBSCRIBE